Vanda Pharmaceuticals
VNDA
VNDA
122 hedge funds and large institutions have $481M invested in Vanda Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 46 increasing their positions, 33 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
122
Holders Change
+13
Holders Change %
+11.93%
% of All Funds
3.41%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
25
Increased
46
Reduced
33
Closed
11
Calls
$11.6M
Puts
$3M
Net Calls
+$8.57M
Net Calls Change
+$4.78M
Top Buyers
| 1 |
CCM
Consonance Capital Management
New York
|
+$16.2M |
| 2 |
Millennium Management
New York
|
+$8.03M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
+$7.74M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$3.4M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$3.1M |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$30.5M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
-$5.2M |
| 3 |
GTC
Ghost Tree Capital
New York
|
-$4.44M |
| 4 |
AC
Armistice Capital
New York
|
-$4.31M |
| 5 |
JGC
J. Goldman & Co
New York
|
-$2.98M |
